Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Michel Symann"'
Publikováno v:
Scandinavian Journal of Haematology. 25:12-18
6 patients with thrombocytopenia and anaemia had fatty marrow replacement at the site of an iliac crest. 52Fe scans showed marked abnormalities of bone marrow distribution. Particularly, the uptake of radioiron into the pelvis was almost absent. The
Publikováno v:
Scandinavian Journal of Haematology. 23:223-226
The diffusion chamber (DC) technique has been applied to the culture of L1210 cells in view of determining their sensitivity to chemotherapic agents. The surviving fraction of L1210 cells cultivated in DC's 4 d after i.v. injection of the host mice w
Autor:
J Gerain, Bernard Vandercam, Michel Symann, Nicole Straetmans, Augustin Ferrant, Michel Moreau, Georges Wauters, Jacques Longueville, Yves Humblet
Publikováno v:
Annals of Hematology. 79:152-157
A total of 101 cancer patients with 121 febrile neutropenia episodes were randomised to receive empirical treatment with i.v. meropenem (1g/8 h) or ceftazidime (2 g/8 h). After 3 days, 89% of patients were on unmodified therapy in the meropenem group
Autor:
M. Salmon, Michel Symann, Jean-Charles Goeminne, Jean-Pascal Machiels, Véronique D'Hondt, Thierry Guillaume
Publikováno v:
Bone Marrow Transplantation. 24:769-775
RT-PCR is increasingly used for the detection of minimal residual disease in solid tumors. Carcinoembryonic antigen (CEA) RT-PCR seemed to be highly specific for detection of tumor cells when tested on PBMC. A very high frequency of RT-PCR amplificat
Autor:
Thierry Guillaume, Michel Symann, Anne-Sophie Govaerts, Babak Bayat, Robert G. Hawley, Marc André, Teresa S. Hawley, Anne Marie Feyens, A Z C Fong
Publikováno v:
Cancer Gene Therapy. 6:447-455
The transfer of genes encoding cytokines into tumor cells has emerged as a new strategy to increase in vivo host reactivity to a variety of tumors. Because gene transfer into tumor cells cannot be easily applied in the clinical setting, we have devel
Publikováno v:
Best Practice & Research Clinical Haematology. 12:293-306
Haematological recovery following autologous peripheral blood stem cell treatment is very rapid. Immune recovery is a more prolonged process requiring a year or more for full reconstitution. Because high-dose chemotherapy followed by autologous perip
Publikováno v:
European Journal of Clinical Investigation. 28:845-855
BACKGROUND: Megakaryocyte polyploidization results from the lack of cytoplasmic separation while the nucleus keeps dividing. METHODS: To investigate the role of actin in the megakaryocyte polyploidization, three human cell lines with megakaryocytic p
Publikováno v:
Blood. 92:1471-1490
APPROXIMATELY 10,000 autologous hematopoietic stem cell (HSC) transplants are performed worldwide each year for malignant diseases.[1][1] Results of randomized trials in recent years suggest that high-dose chemotherapy followed by infusion of autolog
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 12:247-251
Les chimiotherapies a hautes doses pratiquees sous le couvert d'une greffe de cellules souches hematopoietiques sont de plus en pus utilisees pour le traitement d'hemopathies malignes et de tumeurs solides. La presence de cellules tumorales circulant
Publikováno v:
Journal of Clinical Oncology. 12:226-231